Podcast appearances and mentions of mark nolan hill

On this episode, we hear two crazy cases told by Board Certified General Surgeon, Dr. Mark Nolan Hill. The first case we titled the "Unconventional Cure" as Dr. Hill takes a left of center approach to helping a patient with a large phytobezoar. In the second case titled "The Hernia," Dr. Hill brings us back to his experience removing one of the largest abdominal hernia's he had ever seen or heard of.    Hosted by Summer Gilbert and Casey Galpin

Guest: William Parker, MD Host: Mark Nolan Hill, MD For many years, bilateral oopherectomy has been a routine part of hysterectomy. After a certain age, we reasoned that the role of the ovaries in helping women achieve hormonal balance was outweighed by the risks for ovarian cancer, thus offering women their best odds of long-term survival. Yet new evidence on the risks of routine bilateral oopherectomy challenges this conventional wisdom. Is it time we change our practice? Host Dr. Mark Nolan Hill examines the findings with Dr. William Parker, clinical professor of obstetrics and gynecology at the University of California, Los Angeles David Geffen School of Medicine, and a faculty member of the John Wayne Cancer Institute in Santa Monica, California. The lead author of a study published in Obstetrics and Gynecology, Dr. Parker also explores the mechanisms behind the potential risks investigated by his team, ranging from specific cancers to heart disease and all-cause mortality.

Host: Mark Nolan Hill, MD Guest: Jeffrey Klausner, MD, MPH Detection and treatment of HIV in the United States has improved dramatically since the peak of the epidemic here in the 1980s, but there is far more work to be done. HIV transmission is one area of heightened concern, particularly those cases spread by newly infected persons who remain undiagnosed. Though tests are available to diagnose HIV in the acute phase, many experts believe we must improve these tests to really make headway in reducing the incidence of HIV in the United States. Dr. Jeffrey Klausner, a deputy health officer and director of the STD Prevention and Control Services Section at the San Francisco Department of Public Health, joins host Dr. Mark Nolan Hill to lay out the path toward progress in detecting acute cases of HIV infection. Newer, more effective tests are available, but must be adopted around the United States, and as Dr. Klausner looks ahead, a point-of-care rapid exam, though still in development, could eventually change the paradigm for early-stage HIV detection.

Host: Mark Nolan Hill, MD Guest: Anthony Miniaci, MD Early arthritis of the knee is a frustrating and painful condition, especially for our more active patients. Some will begrudgingly accept the end of their adult sports league careers, others will be less inclined to hang up their sneakers. In this case, depending on the severity of the condition, there could be several procedural options, including a new arthroscopic resurfacing technique for those with less severe arthritis: could this be the quickest route back to the playing field? Dr. Anthony Miniaci, executive director of Cleveland Clinic Sports Health and one of the developers of this new procedure, explains why this procedure could be the answer for patients who have failed all biologic procedures, but are not yet ready for a total knee replacement. Which of your patients might be a candidate? Dr. Mark Nolan Hill hosts.

Guest: Joel Saper, MD Host: Mark Nolan Hill, MD Many physicians today feel overburdened by the task of pain management. The current state of pain management stands in sharp contrast to years past, when our options were once relatively limited in the treatment of pain associated with headaches and other ailments. When is it appropriate to prescribe narcotics, if at all, for these conditions? Dr. Joel Saper, director of the Michigan Head Pain and Neurological Institute in Ann Arbor, Michigan, recounts how physicians' sensitivities have changed over the years. Are we now too sensitive to pain control? Dr. Mark Nolan Hill hosts.

Guest: Joel Saper, MD Host: Mark Nolan Hill, MD Though many therapies exist for the treatment of headaches, some chronic headache cases do not respond to prescribed therapies. In a portion of these cases, opioid medications are offered to help patients find relief. But prescription of opioids can present additional problems, including increasingly recurrent headaches. This leads us to the question: which of our patients should receive opioid therapy for their headaches? Dr. Joel Saper, director of the Michigan Head Pain and Neurological Institute in Ann Arbor, Michigan, examines this critical question and much more with host Dr. Mark Nolan Hill. Which patient populations are most vulnerable to the potential problems associated with narcotic therapy? Are we properly advising our patients on the risks of narcotic misuse and overuse, as well as the importance of dose limitations--and if not, how can we improve …

Guest: Marc Bessler, MD Host: Mark Nolan Hill, MD As the field of bariatric and minimally invasive surgery continues to grow, the gastric bypass procedure has grabbed many of the headlines, with solid interest in gastric banding as well. Looking ahead, how might the landscape change? Will a new bariatric procedure emerge as the safest and most effective choice? Host Dr. Mark Nolan Hill welcomes Dr. Marc Bessler, assistant professor of surgery at Columbia University College of Physicians and Surgeons, and director of the Columbia University Center for Metabolic and Weight Loss Surgery, to detail one procedure that could represent the next step in reducing the invasiveness of bariatric surgery: the transoral gastroplasty.

Guest: Selene Parekh, MD, MBA Host: Mark Nolan Hill, MD Ankle injuries extend from the common sprain, to the complex arthritis case that could warrant total joint replacement surgery. With respect to the basic sprain, why do we see so many of these injuries in our practices: are our ankles not strong enough, are we wearing the wrong shoes or are we simply more active than we used to be? What are the keys to a good clinical evaluation for these ankle injuries and what can you counsel your patients to anticipate following a more serious ankle injury? Dr. Selene Parekh, head of the foot and ankle division of the department of orthopaedic surgery at the University of North Carolina School of Medicine, assesses a range of ankle injuries in this conversation with host Dr. Mark Nolan Hill.

Guest: Paul Holman, MD Host: Mark Nolan Hill, MD At first glance, minimally invasive spine surgery sounds like a contradiction in terms: how could an operation on an area of the body so complex, be navigated successfully through only a few simple incisions? Dr. Paul Holman, a neurosurgeon for the Methodist Neurological Institute at the Methodist Hospital in Houston, joins host Dr. Mark Nolan Hill to explore the intricacies of these procedures, as well as the outcomes: how do the results of minimally invasive spine surgery compare with the more traditional open procedure? Dr. Holman also takes a look ahead, envisioning the technologies and techniques of future minimally invasive spine procedures.

Guest: John Dixon, MBBS, PhD Host: Mark Nolan Hill, MD Gastric bypass surgery has received significant attention as an up-and-coming treatment for type 2 diabetes. At the same time, we are also seeing the emergence of encouraging results from laparoscopic gastric banding surgery for patients with diabetes. Dr. John Dixon, associate professor of medicine and head of obesity research at Monash University Medical School in Melbourne, Australia, compares the efficacy of gastric banding surgery with gastric bypass as a treatment for diabetes. Further, some medical experts have been very critical of any form of surgery as a means to reverse lifestyle tendencies that often contribute to the onset of diabetes, including one's propensity to eat too much or an aversion to exercise. Dr. Dixon responds to this notion in this conversation with Dr. Mark Nolan Hill.

Guest: John Dixon, MBBS, PhD Host: Mark Nolan Hill, MD There is mounting evidence that surgery can be a key weapon against diabetes, improving glycemic control or sending the disease into remission entirely. As the scourge of diabetes continues across our country and abroad, safety and efficacy of surgery are two legitimate concerns. How does gastric banding surgery stack up against more traditional therapies for diabetes? What is the key mechanism behind gastric banding: does it reduce the patient's appetite or make the patient ill if they eat too much? Dr. John Dixon, associate professor of medicine and head of obesity research at Monash University Medical School in Melbourne, Australia, details his research team's work to assess the viability of gastric banding surgery. Dr. Mark Nolan Hill hosts.

Host: Mark Nolan Hill, MD Guest: Howard Heit, MD Pain is generally considered to be the most common reason our patients come to see us. Yet it's a phenomenon that we don't fully understand and one that varies widely from patient to patient. With regard to the prescription of potent painkillers like methadone, should the often cryptic nature of pain warrant additional pain management training for practitioners ordering these meds? Dr. Howard Heit, a nationally recognized chronic pain and addiction medicine specialist practicing in northern Virginia, and an assistant clinical professor at the Georgetown University School of Medicine, joins host Dr. Mark Nolan Hill to address the challenges of properly prescribing pain medication. What grade would Dr. Heit give our profession for our overall performance on pain management, and how can we improve that evaluation?

Guest: Howard Heit, MD Host: Mark Nolan Hill, MD A drug that first gained prominence as a treatment for heroin addiction, methadone is now more commonly prescribed by medical practitioners for a range of severe pains. Why are we seeing this rise in methadone use? Are we, as prescribers, doing everything we can to understand the pharmacokinetics and pharmacodynamics of methadone, and to ensure that our patients are also cognizant of the dangers? Dr. Howard Heit, a nationally recognized chronic pain and addiction medicine specialist practicing in northern Virginia, and an assistant clinical professor at the Georgetown University School of Medicine, shares his clinical expertise on the perils of the drug that is now the fastest growing cause of narcotic death in the United States. Dr. Mark Nolan Hill hosts.

Guest: David Felson, MD, MPH Host: Mark Nolan Hill, MD A patient in your office describes the knee pain they have been feeling for an extended period of time. The MRI that you order on their knee reveals meniscal damage. New research is telling us that meniscal tears may be more common than we realize, and further, raises questions as to whether the meniscal tear is really the source of your patient's knee pain. Dr. David Felson, professor of medicine at the Boston University (BU) School of Medicine and professor of epidemiology at the BU School of Public Health, explains that damaged meniscal cartilage may not be directly linked to knee pain. Dr. Mark Nolan Hill hosts.

Host: Mark Nolan Hill, MD Guest: David Felson, MD, MPH Despite previous evidence to suggest that arthroscopic surgery does not improve symptoms associated with osteoarthritis of the knee, the procedure continues to be a common treatment for arthritis. Now, novel data is backing up this earlier research on arthroscopy. Going forward, how will this development impact practice? Host Dr. Mark Nolan Hill talks with Dr. David Felson, professor of medicine at the Boston University (BU) School of Medicine and professor of epidemiology at the BU School of Public Health, about the utility of the procedure, and explores alternative thoughts on the pathogenesis of the pain experienced by this class of patients.

Guest: James Crowe, MD Host: Mark Nolan Hill, MD Preparing for the future by studying the past: With researchers now able to resurrect antibodies to the 1918 influenza pandemic from elderly survivors, how does the technology used to do this potentially lead us to antibodies for other viruses? Can we be sure this immunity is not generated by recent exposure to similar strains? Dr. James Crowe, Jr., professor of microbiology and immunology, and director of the Vanderbilt Program for Vaccine Sciences at Vanderbilt University School of Medicine, and one of the researchers leading this expansive project, explains how we are beginning to learn more about where viruses, including HIV, are most susceptible to being controlled and destroyed. Dr. Mark Nolan Hill hosts.

Host: Mark Nolan Hill, MD Guest: James Crowe, MD Ninety-plus years after the 1918 influenza pandemic, we are just beginning to understand the naturally occurring adaptive immunity of those who were in contact with this devastating virus. As researchers probe survivors of the flu pandemic, all of whom are approaching or have attained centenarian status, what are we learning about their long-lasting immunity to this virus? Can we explain why these people survived this expansive outbreak, just as relatives and friends around them perished? Dr. James Crowe, Jr., professor of microbiology and immunology, and director of the Vanderbilt Program for Vaccine Sciences at Vanderbilt University School of Medicine, and one of the researchers leading this expansive project, shares some of the tricks that his team has used to make these antibodies in this fascinating discussion with Dr. Mark Nolan Hill.

Guest: James Crowe, MD Host: Mark Nolan Hill, MD First published in 2005, the story of how we've come to understand the complete sequence of the 1918 pandemic influenza virus begins years ago, in a remote Alaskan village, and continues today in research across the country. What are we learning about a virus that has taken many decades to comprehend? Dr. James Crowe, Jr., professor of microbiology and immunology, and director of the Vanderbilt Program for Vaccine Sciences at Vanderbilt University School of Medicine, and one of the researchers leading this expansive project, tells host Dr. Mark Nolan Hill that antibody recognition may actually bear a strong resemblance to cognitive memory. What does Dr. Crowe mean by this? Do we know how the immune system would respond if survivors were infected with this influenza virus?

Guest: Roy Steigbigel, MD Host: Mark Nolan Hill, MD In the quest to find therapies for multi-drug resistant HIV, researchers have zeroed in on raltegravir. The latest data indicates this potent agent provides the highest reported virologic suppression rate among multi-drug resistant patients. Is raltegravir proving more effective than antiretrovirals? Does it carry any prominent side effects? Dr. Roy Steigbigel, professor of medicine and pathology, molecular genetics and microbiology, and pharmacological sciences, and founding director of the Comprehensive AIDS Center at the State University of New York at Stony Brook, details his New England Journal of Medicine research on raltegravir therapy for multi-drug resistant HIV with host Dr. Mark Nolan Hill.

Guest: Roy Steigbigel, MD Host: Mark Nolan Hill, MD We are getting our first in-depth look at some of the research behind raltegravir, a powerful therapy for multi-drug resistant HIV infection already approved by the FDA. How is this raltegravir data impacting current clinical strategies for attacking the virus in multi-drug resistant patients? Host Dr. Mark Nolan Hill probes this question and much more with Dr. Roy Steigbigel, professor of medicine and pathology, molecular genetics and microbiology, and pharmacological sciences, and founding director of the Comprehensive AIDS Center at the State University of New York at Stony Brook.

Host: Mark Nolan Hill, MD Guest: Randi Hagerman, MD It's responsible for more than five percent of all cases of autism, and it's the most common cause of inherited mental retardation. But are we as familiar as we need to be with Fragile X syndrome, and a series of genetic conditions related to Fragile X? Host Dr. Mark Nolan Hill welcomes Dr. Randi Hagerman, professor and endowed chair of Fragile X research, and medical director of the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute at the University of California, Davis School of Medicine, for a stimulating conversation about our rapidly expanding knowledge of these genetic conditions. How do the signs and symptoms manifest in children, and how does Fragile X impact our elder generations?

Guest: Jamie Hutchison, MD Host: Mark Nolan Hill, MD A young patient is brought into the emergency department having suffered a traumatic brain injury. Hypothermia may be considered as part of the treatment regimen. If so, how soon after the injury should treatment begin, and how long should treatment last? Dr. Jamie Hutchison, associate professor of critical care medicine and pediatrics at the University of Toronto, and research director of critical care medicine at the Hospital for Sick Children in Toronto, explains the mechanism used for cooling and examines potential links between data on hypothermia treatment for adults and similar therapy for children. Dr. Mark Nolan Hill hosts.

Guest: Jamie Hutchison, MD Host: Mark Nolan Hill, MD Traumatic brain injuries can present a lifetime of consequences. Previous studies indicate that hypothermia may be a viable treatment option, but little data has demonstrated efficacy for our youngest patients. Is hypothermia effective in treating pediatric brain trauma patients in a more rigorous research setting? What are the key mechanisms behind this query? Dr. Jamie Hutchison, associate professor of critical care medicine and pediatrics at the University of Toronto, and research director of critical care medicine at the Hospital for Sick Children in Toronto, evaluates the utility of hypothermia treatment for pediatric traumatic brain injuries with host Dr. Mark Nolan Hill.

Host: Mark Nolan Hill, MD Guest: Randi Hagerman, MD We are rapidly learning more about the genetic disorder Fragile X syndrome, and a series of conditions related to Fragile X. We're also seeing great progress in promising therapies under investigation. How will these therapies, along with other treatment strategies, improve the lives of children and families affected by Fragile X and related conditions? Who should supervise care, and should treatment for children be coordinated with care of potentially affected relatives? Dr. Randi Hagerman, professor and endowed chair of Fragile X research, and medical director of the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute at the University of California, Davis School of Medicine, shares her expansive expertise on Fragile X syndrome and associated conditions with host Dr. Mark Nolan Hill. If a child is diagnosed with Fragile X, is genetic screening inevitably warranted for parents and grandparents?

Host: Mark Nolan Hill, MD Guest: Randi Hagerman, MD Diagnosis of the genetic disorder Fragile X syndrome can be devastating for our young patients and their families, knowing that both the patient and their elders can be affected by this condition. Should we expand current screening measures for Fragile X? As clinicians, how do we guide patients and their families through this process of understanding their diagnosis? Dr. Randi Hagerman, professor and endowed chair of Fragile X research, and medical director of the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute at the University of California, Davis School of Medicine, joins host Dr. Mark Nolan Hill to talk about the nuances of this genetic condition.

Guest: Jim Hu, MD, MPH Host: Mark Nolan Hill, MD We are still working to minimize the major risks of complications involved in minimally invasive prostatectomy. This becomes even more important as more patients undergo these procedures. How has the training and certification process impacted our success? What improvements can we expect in this minimally invasive technique to treat prostate cancer in the years to come? For answers to these questions and many more, host Dr. Mark Nolan Hill welcomes Dr. Jim Hu, assistant professor of surgery at Harvard Medical School, and director of minimally invasive urologic oncology at Brigham and Women's Hospital and the Dana Farber Cancer Institute in Boston.

Guest: Jim Hu, MD, MPH Host: Mark Nolan Hill, MD Research indicates that demand for minimally invasive prostatectomy is growing, from 12 percent to more than 30 percent of our candidate patients over a recent two-year span. But research also tells us that there are still drawbacks to a laparoscopic approach to prostate cancer. What are the immediate and enduring pitfalls to laparoscopy, and are these concerns outweighed by the perceived benefits? Dr. Jim Hu, assistant professor of surgery at Harvard Medical School, and director of minimally invasive urologic oncology at Brigham and Women's Hospital and the Dana Farber Cancer Institute in Boston, explains why some surgeons may stick with the open procedure, even as others move ahead with the laparoscopic approach. Dr. Mark Nolan Hill hosts.

Guest: Dana Christian Lynge, MD Host: Mark Nolan Hill, MD Dropping reimbursement for general surgical procedures and increased everyday expenses are two issues, in addition to many others, that make the future viability of a general surgery practice a more difficult proposition. What if this disturbing trend continues? Could medicine withstand the loss of general surgery altogether? Dr. Dana Christian Lynge, associate professor of surgery at the University of Washington School of Medicine, and practicing general surgeon, peers into a theoretical future without general surgeons. What does he see? Dr. Mark Nolan Hill hosts.

Guest: Dana Christian Lynge, MD Host: Mark Nolan Hill, MD A nationwide survey reveals that the number of general surgeons has dropped 25 percent in the past 25 years. A continuation of this decline could have profound implications on patient populations that depend on general surgeons. What are the key demographic concerns surrounding a potential national shortage of general surgeons? Dr. Dana Christian Lynge, associate professor of surgery at the University of Washington School of Medicine, and practicing general surgeon, details his research, published in the Archives of Surgery, on a nationwide shortfall of general surgeons. Dr. Mark Nolan Hill hosts.

Guest: Dana Christian Lynge, MD Host: Mark Nolan Hill, MD Thirty to forty years ago, the field of general surgery was truly flourishing. General surgeons treated patients for an array of surgical conditions, as the concept of present day sub-specialties had yet to take hold. What has led to this significant shift in the focus of general surgery? Host Dr. Mark Nolan Hill welcomes Dr. Dana Christian Lynge, associate professor of surgery at the University of Washington School of Medicine, and practicing general surgeon, to discuss the evolution of general surgery in the context of Dr. Lynge's research in the Archives of Surgery on the national shortage of general surgeons.

Guest: Beverly Green, MD, MPH Host: Mark Nolan Hill, MD The Internet plays such an integral role in so many of our lives, it's only natural to consider expanding its position in medicine. This process is underway, and moving rapidly in some areas, with the first large-scale, randomized clinical trial probing web-based hypertension interventions. How can we, as clinicians, adapt to new digital mechanisms for providing care? Does this particular hypertension concept mesh with the idea of a fee-for-service payment plan? Dr. Beverly Green, an affiliate investigator at the Group Health Center for Health Studies in Seattle, and the lead author of research published in JAMA on innovative web-based interventions for patients with uncontrolled hypertension, explains more about this collaborative approach to care with host Dr. Mark Nolan Hill.

Guest: Beverly Green, MD, MPH Host: Mark Nolan Hill, MD For each 10 millimeter drop toward normal systolic blood pressure, research tells us that heart disease mortality risk drops by an average of 30 percent. New internet-based hypertension interventions are proving they could produce this steep, impressive decline. How can these web initiatives help our patients take a more active role in their care? If patients are based at home, how can we ensure that they are following proper protocol for taking blood pressure measurements? Host Dr. Mark Nolan Hill takes a closer look at these issues and more with Dr. Beverly Green, an affiliate investigator at the Group Health Center for Health Studies in Seattle, and the lead author of research published in JAMA on innovative web-based interventions for patients with uncontrolled hypertension.

Guest: Beverly Green, MD, MPH Host: Mark Nolan Hill, MD By the year 2025, it is predicted that more than 1.5 billion people around the world will have hypertension, accounting for nearly half of heart disease risk and three-quarters of stroke risk. With new Web-based technologies emerging as potential treatment options, how will we change our approach to care? How might these programs impact the treatment of hypertension on a global scale? Dr. Beverly Green, an affiliate investigator at the Group Health Center for Health Studies in Seattle, and the lead author of research published in JAMA on innovative Web-based interventions for patients with uncontrolled hypertension, peers into the future of hypertension care during this discussion with host Dr. Mark Nolan Hill.

Guest: Alan Hemming, MD Host: Mark Nolan Hill, MD For patients with severe hepatic malignancy, attempts to cure their illness are rarely, if ever, successful. We're learning, however, that a more aggressive surgical approach may extend survival rates well beyond those of our previous techniques. Dr. Alan Hemming, professor of surgery and chief of transplantation and hepatobiliary surgery at the University of Florida College of Medicine, details his pursuit of novel measures to surgically address severe hepatic malignancies with host Dr. Mark Nolan Hill.

Guest: Alan Hemming, MD Host: Mark Nolan Hill, MD In recent years, extensive debate has centered around the possibility of further extending the scope of hepatic resection. With research now demonstrating the potential value of extended resection, will more patients be offered this as a treatment option? Are there common complications to consider when evaluating a candidate for this surgery? Dr. Alan Hemming, professor of surgery and chief of transplantation and hepatobiliary surgery at the University of Florida College of Medicine, explains the next steps toward entrenching extended resection in our arsenal of treatment for hepatic disease. Dr. Mark Nolan Hill hosts.

Guest: Alan Hemming, MD Host: Mark Nolan Hill, MD As we extend the bounds of surgical resection for hepatic malignancies, we overcome previously held limitations of our efforts against liver disease. How do our techniques and theories on hepatic resection also relate back to hepatic transplantation? Are we developing more effective strategies to protect the liver during surgery? Dr. Alan Hemming, professor of surgery and chief of transplantation and hepatobiliary surgery at the University of Florida College of Medicine, also peers into the future to examine the potential role of laparoscopy or endoscopy in hepatic surgery. Dr. Mark Nolan Hill hosts.

Guest: Richard Lipton, MD Host: Mark Nolan Hill, MD For decades, researchers and medical professionals have pursued a more concrete understanding of migraine headaches. We're still not sure of the origin of migraines, but we may have found a device that minimizes their impact. Dr. Richard Lipton, professor and vice chair of neurology at Albert Einstein College of Medicine, and director of the Montefiore Headache Center in New York City, shares details on this device with host Dr. Mark Nolan Hill.

Guest: Joel Saper, MD Host: Mark Nolan Hill, MD The sources of migraine headaches have long been a mystery in medicine. Over the years, many theories have come and gone, with few enduring leads on this debilitating problem that affects many of our patients. Could finding a new therapy for migraines bring us back to the root cause of this condition? Dr. Joel Saper, director of the Michigan Head Pain and Neurological Institute in Ann Arbor, discusses his clinical research on occipital nerve stimulation as treatment for migraine headaches with host Dr. Mark Nolan Hill.

Guest: Michael Marin, MD Host: Mark Nolan Hill, MD Research data indicates an increasingly significant percentage of all elective aortic aneurysm repairs are endovascular procedures. How are new tools for endovascular repair improving our ability to provide minimally invasive options to our patients? How common are subsequent re-interventions following endovascular repair, and what is the key to finding success in this secondary procedure? Dr. Michael Marin, professor and chair of surgery at Mount Sinai School of Medicine in New York City, tells host Dr. Mark Nolan Hill how we are addressing the biggest challenges in endovascular aortic repair.

Guest: Michael Marin, MD Host: Mark Nolan Hill, MD Techniques for open repair of aortic aneurysms have remained remarkably steady over the past several decades. But with the trend toward minimally-invasive procedures sweeping across medicine, how are advancing techniques in endovascular repair of aortic aneurysms enhancing the standard of care? How do the current success rates for emergent and elective endovascular procedures compare with open repair? Dr. Michael Marin, professor and chair of surgery at Mount Sinai School of Medicine in New York City, examines these questions and more with Dr. Mark Nolan Hill.

Guest: Marilyn Moffat, PhD Host: Mark Nolan Hill, MD Exercise and physical therapy are commonly touted as keys to preventing an array of conditions: heart attack, depression, cancer and more. But how does the exercise equation change once a patient is diagnosed with an illness? How does a patient's perspective on their disease impact their outlook on exercise? Dr. Marilyn Moffat, professor of physical therapy at New York University and an internationally-respected voice in physical therapy, provides her perspective on the value of exercise in encouraging patients stricken with illness to work beyond the boundary of what they initially believed they could accomplish. Dr. Mark Nolan Hill hosts.

Guest: Marilyn Moffat, PhD Host: Mark Nolan Hill, MD We are acutely aware of the value of exercise in maintaining good health. But how do the benefits of exercise and physical therapy apply specifically to patients who are coping with a disease or an illness? Dr. Marilyn Moffat, professor of physical therapy at New York University and an internationally-respected voice in physical therapy, joins host Dr. Mark Nolan Hill for a conversation about exercise regimens for patients already burdened by illness. Are our patients receiving exercise and therapy guidance that is rigorous enough to accelerate the healing process?

Guest: Bert Mandelbaum, MD Host: Mark Nolan Hill, MD It's an array of sporting events, many occurring simultaneously, in sites and cities across a nation. The 2008 Summer Olympic Games in China presents an extraordinary challenge, in terms of providing health care to injured athletes and suddenly-ill spectators alike. Dr. Bert Mandelbaum, a practicing orthopedic surgeon and president of the Santa Monica Orthopedic and Sports Medicine Research Foundation in Santa Monica, Calif., served as chief medical officer (CMO) for the 1999 and 2003 Women's World Cup of Soccer. He joins host Dr. Mark Nolan Hill to discuss the challenges of providing care in this setting. For instance, how does the CMO coordinate with the various team physicians, many of whom will not possess the necessary license to practice medicine in the country where their team is playing?

Guest: Bert Mandelbaum, MD Host: Mark Nolan Hill, MD Intense competition and year-round scheduling demands are now common trademarks of adolescent sports. As a result, we see more and more sports-related injuries, including the all-too-frequent anterior cruciate ligament (ACL) injuries. Dr. Bert Mandelbaum, president of the Santa Monica Orthopedic and Sports Medicine Research Foundation in Santa Monica, Calif., and principal investigator of the ACL Prevention Project, shares details of his potentially groundbreaking program, with results published in the American Journal of Sports Medicine. When should young athletes begin this prevention regimen? Taking the mechanisms of prevention a step further, can we teach athletes to run, jump and land in ways that will lessen their risk of injury? Dr. Mark Nolan Hill hosts.

Guest: Bert Mandelbaum, MD Host: Mark Nolan Hill, MD We're making great progress in the diagnosis and treatment of anterior cruciate ligament (ACL) injuries suffered by young athletes. It's no longer the injury that ends a sports career, but an ACL tear can still quickly end a season. Taking our work a step further, how can we equip our athletes with strategies to prevent ACL injuries before they happen? Dr. Bert Mandelbaum, president of the Santa Monica Orthopedic and Sports Medicine Research Foundation in Santa Monica, California, is the principal investigator of the ACL Prevention Project, with results published in the American Journal of Sports Medicine. He shares details of this potentially groundbreaking program with host Dr. Mark Nolan Hill.

Host: Mark Nolan Hill, MD Guest: Maria Simbra, MD It's not uncommon for someone to change careers after many years in one field. Not too many physicians, however, make the weighty decision to change professions, particularly to become a full-time medical television journalist. But that's exactly the trajectory which Dr. Maria Simbra has set for her career. As a board-certified neurologist transitioning to permanent work as a medical reporter for KDKA-TV, the CBS network station in Pittsburgh, Dr. Simbra has worked very hard to refine her standing as a medical professional. What advice would she give to those of us who have considered, or are still considering, a change in profession? She also talks with host Dr. Mark Nolan Hill about the politics of the newsroom, and how this compares to the politics of medicine.

Guest: Richard Salvi, PhD Host: Mark Nolan Hill, MD Dr. Richard Salvi, professor in the department of communicative disorders and sciences, and director of the Center for Hearing Deafness at the State University of New York at Buffalo School of Medicine, outlines potentially fertile areas of research in our pursuit of more effective treatment regimens for tinnitus with host Dr. Mark Nolan Hill. We are still working toward a cure for the condition, but there have been major advances in our treatment of the physiologic and psychologic triggers for the condition. What are the most important investigational issues in the future of tinnitus research?

Guest: Richard Salvi, PhD Host: Mark Nolan Hill, MD A neurological condition that can be highly distressing, tinnitus affects as much as fifteen percent of our population, according to some surveys. How should medical professionals counsel their patients on this condition? Are we moving closer to understanding the basic triggers of tinnitus? Dr. Richard Salvi, professor in the department of communicative disorders and sciences, and director of the Center for Hearing Deafness at the State University of New York at Buffalo School of Medicine, joins host Dr. Mark Nolan Hill to discuss the impact of tinnitus on the daily lives of our patients.

Guest: Richard Salvi, PhD Host: Mark Nolan Hill, MD Major advances in tinnitus research are making investigators very optimistic about our ability to treat the condition now and in the future. What are the most effective therapeutic measures for tinnitus? What are the specific mechanisms behind our various treatment options? Dr. Richard Salvi, professor in the department of communicative disorders and sciences, and director of the Center for Hearing Deafness at the State University of New York at Buffalo School of Medicine, details our ongoing pursuit of optimal treatment strategies for tinnitus with host Dr. Mark Nolan Hill.

Guest: Richard Salvi, PhD Host: Mark Nolan Hill, MD We're learning more about tinnitus at a steady clip, as researchers use newer imaging modalities to help us understand the origin of the condition, and consider lifestyle and behavioral modifications that may limit its effects. Host Dr. Mark Nolan Hill explores the main causes of tinnitus with Dr. Richard Salvi, professor in the department of communicative disorders and sciences, and director of the Center for Hearing Deafness at the State University of New York at Buffalo School of Medicine.